Nitrofurantoin

EsbL ; Escherichia coli







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34161207 Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections. 2022 1
2 32120467 Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka 2019 Dec 31 2
3 28992981 Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options. 2018 Apr 13 1
4 29563719 Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae. 2018 Jan-Mar 1
5 28377310 Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study. 2017 Dec 1
6 26414659 The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011. 2016 Feb 1
7 27092771 [Uropathogen pattern and antimicrobial susceptibility in positive urinary cultures isolates from paediatric patients]. 2016 Jun 1
8 26167826 [Extended-spectrum beta-lactamase production by Enterobacteriaceae isolates from urine cultures of outpatients: results of a 7-year follow-up]. 2015 Apr 1
9 24666610 Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria. 2014 Mar 25 1
10 25179392 Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. 2014 Dec 1
11 26120573 Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda. 2014 Dec 1
12 24502096 [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients]. 2013 Nov-Dec 1
13 22508296 Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada. 2012 Jul 1
14 22882781 Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. 2012 Dec 2
15 20387724 [Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region]. 2010 Feb 1
16 18154548 Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. 2008 Jan 1
17 18423165 [Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study]. 2008 Apr 12 1
18 17642726 Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. 2004 Jul-Sep 1